These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4461785)

  • 1. Role of dopamine and norepinephrine in the chemistry of reward.
    Fibiger HC; Phillips AG
    J Psychiatr Res; 1974; 11():135-43. PubMed ID: 4461785
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative involvement of dopamine and noradrenaline in rate-free self-stimulation in substania nigra, lateral hypothalamus, and mesencephalic central gray.
    Liebman JM; Butcher LL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):167-94. PubMed ID: 4152814
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-stimulation reward pathways: norepinephrine vs dopamine.
    Stein L; Belluzzi JD; Ritter S; Wise CD
    J Psychiatr Res; 1974; 11():115-24. PubMed ID: 4461783
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic and noradrenergic substrates of positive reinforcement: differential effects of d- and l-amphetamine.
    Phillips AG; Fibiger HC
    Science; 1973 Feb; 179(4073):575-7. PubMed ID: 4686463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological and molecular biochemistry.
    Andén NE; Bartholini G; Corrodi H; Csillik B; De Robertis E; Dresse A; Fuxe K; Gerebtzoff MA; Glowinski J; Hansson E; Hökfelt T; Renson J; Roos BE
    Mod Probl Pharmacopsychiatry; 1970; 5():1-11. PubMed ID: 4348145
    [No Abstract]   [Full Text] [Related]  

  • 6. Intracranial self-stimulation in rats as a function of various stimulus parameters. II. Influence of haloperidol, pimozide and pipamperone on medial forebrain bundle stimulation with monopolar electrodes.
    Wauquier A; Niemegeers CJ
    Psychopharmacologia; 1972; 27(3):191-202. PubMed ID: 4642460
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased intracranial self-stimulation after neuroleptics or 6-hydroxydopamine: evidence for mediation by motor deficits rather than by reduced reward.
    Fibiger HC; Carter DA; Phillips AG
    Psychopharmacology (Berl); 1976 May; 47(1):21-7. PubMed ID: 959465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antagonism of the effect of dopamine and norepinephrine on some isolated organs].
    Ferrini R; Miragoli G
    Boll Soc Ital Biol Sper; 1973 Jul; 49(11):648-52. PubMed ID: 4799566
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
    Lal H; Gianutsos G; Puri SK
    Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089
    [No Abstract]   [Full Text] [Related]  

  • 11. Catecholamines and self-stimulation: pharmacological differences between near- and far-lateral hypothalamic sites.
    Stephens DN; Herberg LJ
    Brain Res; 1975 Jun; 90(2):348-51. PubMed ID: 1139312
    [No Abstract]   [Full Text] [Related]  

  • 12. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.
    Leibowitz SF
    Brain Res; 1975 Nov; 98(3):529-45. PubMed ID: 1182535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats.
    Rolinski Z; Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):385-99. PubMed ID: 4149038
    [No Abstract]   [Full Text] [Related]  

  • 15. Substantia nigra self-stimulation: dependence on noradrenergic reward pathways.
    Belluzzi JD; Ritter S; Wise CD; Stein L
    Behav Biol; 1975 Jan; 13(1):103-11. PubMed ID: 1111501
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine and the pharmacology of schizophrenia: the state of the evidence.
    Matthysse S
    J Psychiatr Res; 1974; 11():107-13. PubMed ID: 4218872
    [No Abstract]   [Full Text] [Related]  

  • 17. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.
    Ungerstedt U
    Acta Physiol Scand Suppl; 1971; 367():49-68. PubMed ID: 4332692
    [No Abstract]   [Full Text] [Related]  

  • 18. D- and l-amphetamine differentially mediates self-stimulation in rat dorsal midbrain area.
    Ellman SJ; Ackermann RF; Bodnar RJ; Jackler F; Steiner SS
    Physiol Behav; 1976 Jan; 16(1):1-7. PubMed ID: 1273106
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of catecholamine-depleting drugs and amphetamine on self-stimulation of brain following various 6-hydroxydopamine treatments.
    Cooper BR; Cott JM; Breese GR
    Psychopharmacologia; 1974 Jul; 37(3):235-48. PubMed ID: 4851731
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.